Orion OYJ (OTCMKTS:ORINY) & Sonoma Pharmaceuticals (NASDAQ:SNOA) Head to Head ContrastDefense World · Oct 13, 2026
Financial Contrast: Sonoma Pharmaceuticals (NASDAQ:SNOA) versus Indivior (NASDAQ:INDV)Defense World · Sep 25, 2026
Sonoma Pharmaceuticals (NASDAQ:SNOA) & Harmony Biosciences (NASDAQ:HRMY) Critical AnalysisDefense World · Sep 8, 2026
Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDAAccesswire · Aug 6, 2026
Sonoma Pharmaceuticals Turns EBITDA Positive for First Time with Record Quarterly RevenueBenzinga · Aug 6, 2026Sonoma Pharmaceuticals, Inc. specializes in the creation and distribution of stabilized hypochlorous acid (HOCl) products. These offerings address a diverse range of medical and health needs, including wound management, veterinary care, ocular hygiene, oral health, and various dermatological conditions. The company's market reach extends across the United States, Latin America, Europe, and other international territories.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 6, 2026 | -$0.30 | $0.02 | Beat |
| Jun 16, 2026 | -$0.24 | -$0.33 | Miss |
| Feb 4, 2026 | -$0.29 | -$0.48 | Miss |
| Nov 6, 2025 | -$0.31 | -$0.32 | Miss |
| Aug 7, 2025 | -$0.51 | -$0.76 | Miss |
| Jun 16, 2025 | -$0.73 | -$0.15 | Beat |